Lipid profile disturbances may predispose psoriatic patients to liver dysfunction.

INTRODUCTION

Psoriasis is a chronic inflammatory disease associated with metabolic disturbances and liver dysfunction. Both serum fatty acids (FA) and ceramides (Cer) have structural functions but also are signal molecules that could be involved in the pathogenesis of liver dysfunction.

AIM

To assess the concentration of the circulating FA and Cer in correlation with the alanine aminotransferase (ALT) blood level in psoriatic patients. In addition, we have examined the relationship between ALT concentration and severity of the disease and inflammation markers.

MATERIAL AND METHODS

Eighty-five patients with psoriasis and 32 healthy controls were enrolled in the study. Patients were divided into 2 groups according to ALT blood levels. Serum concentration of 14 FA and 14 Cer were measured by gas-liquid chromatography. The results were correlated with the Psoriasis Area and Severity Index (PASI), serum lipid profile, and inflammatory markers.

RESULTS

We observed higher PASI score ( = 0.01) and higher C-reactive protein ( = 0.02) concentration in the group of psoriatic patients with high ALT. Serum ALT positively correlated with saturated fatty acids (SFA) ( = 0.01, = 0.27) and SFA/unsaturated fatty acids (UFA) ratio ( = 0.01, = 0.26). ALT negatively correlated with UFA level ( = 0.008, = -0.28). Lignoceric ceramide positively correlated with ALT level ( = 0.22; = 0.045) in psoriatic patients.

CONCLUSIONS

Patients with severe psoriasis are predisposed to the development of liver dysfunction. We have demonstrated disturbances of serum fatty acid and sphingolipid profile in psoriatic patients, which may trigger liver disease.